|
PETNECK 2: PET-CT guided, symptom-based, patient-initiated surveillance versus clinical follow-up in advanced head neck cancer
PETNECK 2: PET-CT guided, symptom-based, patient-initiated surveillance versus clinical follow-up in advanced head neck cancer
|
Jane Wolstenholme,
Liz Stokes
|
|
SWEET: Improving outcomeS for Women diagnosed with early breast cancer through adhErence to adjuvant Endocrine Therapy
SWEET: Improving outcomeS for Women diagnosed with early breast cancer through adhErence to adjuvant Endocrine Therapy
|
Jane Wolstenholme,
Helen Dakin
|
|
A phase III trial of intensity-modulated proton beam therapy versus intensity-modulated radiotherapy for multi-toxicity reduction in oropharyngeal cancer
A phase III trial of intensity-modulated proton beam therapy versus intensity-modulated radiotherapy for multi-toxicity reduction in oropharyngeal cancer
|
Jane Wolstenholme,
Liz Stokes
|
|
A randomised controlled trial of TRANSrectal biopsy versus Local Anaesthetic Transperineal biopsy Evaluation (TRANSLATE) of potential clinically significant prostate cancer
A randomised controlled trial of TRANSrectal biopsy versus Local Anaesthetic Transperineal biopsy Evaluation (TRANSLATE) of potential clinically significant prostate cancer
|
Jane Wolstenholme,
Filipa Landeiro
|
|
The Integration and Analysis of Data using Artificial Intelligence to Improve Patient Outcomes with Thoracic Diseases (DART) research programme
The Integration and Analysis of Data using Artificial Intelligence to Improve Patient Outcomes with Thoracic Diseases (DART) research programme
|
Sarah Wordsworth,
Rositsa Koleva-Kolarova,
Liz Stokes
|
|
AgeX
AgeX
|
Toral Gathani,
Isobel Barnes,
Jane Wolstenholme
|
|
EndoNET: Randomised controlled trial to evaluate the effectiveness of neoadjuvant endocrine treatment in postmenopausal women with early breast cancer
EndoNET: Randomised controlled trial to evaluate the effectiveness of neoadjuvant endocrine treatment in postmenopausal women with early breast cancer
|
Filipa Landeiro
|
|
RaPartial prostate Ablation versus Radical prosTatectomy (PART) in intermediate risk unilateral clinically localised prostate cancer
RaPartial prostate Ablation versus Radical prosTatectomy (PART) in intermediate risk unilateral clinically localised prostate cancer
|
Jane Wolstenholme,
Filipa Landeiro
|
